ArticleRheumatology (Oxford, England)2018
Comment on: Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials.
Duygu Tecer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.